These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 22112485)

  • 1. Hepatocellular carcinoma of the liver.
    Block T; Mehta AS; London WT
    Cancer Biomark; 2010; 9(1-6):375-83. PubMed ID: 22112485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The search for biomarkers of hepatocellular carcinoma and the impact on patient outcome.
    Black AP; Mehta AS
    Curr Opin Pharmacol; 2018 Aug; 41():74-78. PubMed ID: 29772420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunodiagnostic Biomarkers for Hepatocellular Carcinoma (HCC): The First Step in Detection and Treatment.
    Xing M; Wang X; Kiken RA; He L; Zhang JY
    Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34200243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs as biomarkers for hepatocellular carcinoma diagnosis and prognosis.
    He S; Zhang DC; Wei C
    Clin Res Hepatol Gastroenterol; 2015 Sep; 39(4):426-34. PubMed ID: 25746139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for the early diagnosis of hepatocellular carcinoma.
    Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
    World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocellular carcinoma, a unique tumor with a lack of biomarkers.
    Debes JD; Carrera E; Mattos AZ; Prieto JE; Boonstra A;
    Ann Hepatol; 2019; 18(6):786-787. PubMed ID: 31494068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B Virus (HBV) Infection and Hepatocellular Carcinoma- New Insights for an Old Topic.
    Yan SY; Fan JG; Qio L
    Curr Cancer Drug Targets; 2017; 17(6):505-511. PubMed ID: 27677954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening and detection of hepatocellular carcinoma.
    Simpson HN; McGuire BM
    Clin Liver Dis; 2015 May; 19(2):295-307. PubMed ID: 25921664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel molecular targets for diagnosis and treatment of hepatocellular carcinoma.
    Ma L; Ji L; Yu Y; Wang J
    Discov Med; 2015 Jan; 19(102):7-14. PubMed ID: 25636956
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocellular carcinoma tumour markers: current role and expectations.
    Rich N; Singal AG
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):843-53. PubMed ID: 25260312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics.
    Masuda T; Miyoshi E
    Clin Chem Lab Med; 2011 Jun; 49(6):959-66. PubMed ID: 21428856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of cancer-testis antigens as biomarkers for the diagnosis and treatment of hepatocellular carcinoma.
    Grizzi F; Franceschini B; Hamrick C; Frezza EE; Cobos E; Chiriva-Internati M
    J Transl Med; 2007 Jan; 5():3. PubMed ID: 17244360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum markers of hepatocellular carcinoma.
    Malaguarnera G; Giordano M; Paladina I; Berretta M; Cappellani A; Malaguarnera M
    Dig Dis Sci; 2010 Oct; 55(10):2744-55. PubMed ID: 20339916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma.
    Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD
    World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel biomarkers in hepatocellular carcinoma.
    De Stefano F; Chacon E; Turcios L; Marti F; Gedaly R
    Dig Liver Dis; 2018 Nov; 50(11):1115-1123. PubMed ID: 30217732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic analysis and translational perspective of hepatocellular carcinoma: Identification of diagnostic protein biomarkers by an onco-proteogenomics approach.
    Chiou SH; Lee KT
    Kaohsiung J Med Sci; 2016 Nov; 32(11):535-544. PubMed ID: 27847095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Significance of Annexin A4 as a Biomarker in the Early Diagnosis of Hepatocellular Carcinoma.
    Saad ZM; Fouad Y; Ali LH; Hassanin TM
    Asian Pac J Cancer Prev; 2020 Sep; 21(9):2661-2665. PubMed ID: 32986366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glypican-3: A promising biomarker for hepatocellular carcinoma diagnosis and treatment.
    Zhou F; Shang W; Yu X; Tian J
    Med Res Rev; 2018 Mar; 38(2):741-767. PubMed ID: 28621802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs in the Occurrence and Development of Primary Hepatocellular Carcinoma.
    Xu J; Li J; Zheng TH; Bai L; Liu ZJ
    Adv Clin Exp Med; 2016; 25(5):971-975. PubMed ID: 28028963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple "Omics" data-based biomarker screening for hepatocellular carcinoma diagnosis.
    Liu XN; Cui DN; Li YF; Liu YH; Liu G; Liu L
    World J Gastroenterol; 2019 Aug; 25(30):4199-4212. PubMed ID: 31435173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.